Understanding the Mechanism of Ferroptosis in Neurodegenerative Diseases
Frontiers in Bioscience-Landmark · 20.08.2024 · 29 (8)
DOI: 10.31083/j.fbl2908291 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 20.08.2024. Verfasst von Jiazi Ma und 9 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Academy of Occupational Health and Occupational Medicine, Shandong First Medical University & Shandong Academy of Medical Sciences, 250062 J…. Hauptthemen laut MEDLINE: Ferroptosis, Neurodegenerative Diseases, Iron. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China (NSFC), Natural Science Foundation of Shandong Province, Shandong Province Medical and Health Technology Development Plan.
Abstract (Originalsprache)
Neurodegenerative disorders are typified by the progressive degeneration and subsequent apoptosis of neuronal cells. They encompass a spectrum of conditions, including Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), Huntington’s disease (HD), epilepsy, brian ischemia, brian injury, and neurodegeneration with brain iron accumulation (NBIA). Despite the considerable heterogeneity in their clinical presentation, pathophysiological underpinning and disease trajectory, a universal feature of these disorders is the functional deterioration of the nervous system concomitant with neuronal apoptosis. Ferroptosis is an iron (Fe)-dependent form of programmed cell death that has been implicated in the pathogenesis of these conditions. It is intricately associated with intracellular Fe metabolism and lipid homeostasis. The accumulation of Fe is observed in a variety of neurodegenerative diseases and has been linked to their etiology and progression, although its precise role in these pathologies has yet to be elucidated. This review aims to elucidate the characteristics and regulatory mechanisms of ferroptosis, its association with neurodegenerative diseases, and recent advances in ferroptosis-targeted therapeutic strategies. Ferroptosis may therefore be a critical area for future research into neurodegenerative diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shandong Academy of Occupational Health and Occupational Medicine, Shandong First Medical University & Shandong Academy of Medical Sciences, 250062 Jinan, Shandong, China.
- Public Health Monitoring and Evaluation Institute of Shandong Provincial Center for Disease Control and Prevention, 250000 Jinan, Shandong, China.
- Department of Neurology, Affiliated Hospital of Qinghai University, 810000 Xining, Qinghai, China.
- Department of Respiratory Medicine, Children's Hospital Affiliated to Shandong University, 250022 Jinan, Shandong, China.
Förderung
- National Natural Science Foundation of China (NSFC)
- Natural Science Foundation of Shandong Province
- Shandong Province Medical and Health Technology Development Plan
- Shandong Province Traditional Chinese Medicine Science and Technology Plan
- Jinan Science and Technology Plan
Zitieren
APA
Ma, J., Liu, J., Chen, S., Zhang, W., Wang, T., Cao, M., Yang, Y., Du, Y., Cui, G., & Du, Z. (2024). Understanding the Mechanism of Ferroptosis in Neurodegenerative Diseases. Frontiers in Bioscience-Landmark, 29(8). https://doi.org/10.31083/j.fbl2908291
Vancouver
Ma J, Liu J, Chen S, Zhang W, Wang T, Cao M, et al. Understanding the Mechanism of Ferroptosis in Neurodegenerative Diseases. Frontiers in Bioscience-Landmark. 2024;29(8). doi:10.31083/j.fbl2908291
BibTeX
@article{Ma2024,
author = {Ma, Jiazi and Liu, Jianwei and Chen, Shangya and Zhang, Wanxin and Wang, Tian and Cao, Mao and Yang, Yong and Du, Yilun and Cui, Guanqun and Du, Zhongjun},
title = {Understanding the Mechanism of Ferroptosis in Neurodegenerative Diseases},
journal = {Frontiers in Bioscience-Landmark},
year = {2024},
volume = {29},
number = {8},
doi = {10.31083/j.fbl2908291}
}
EUVIMED